Orchard therapeutics plc (ORTX)
CashFlow / TTM
Mar'20Mar'19
Cash flows from operating activities:
Net loss attributable to ordinary shareholders

0

0

Adjustments to reconcile net loss to net cash used in operating activities:
Depreciation

0

0

Non-cash share-based compensation

0

0

Amortization of Strimvelis loss provision

0

0

Other non-cash adjustments

0

0

Changes in operating assets and liabilities:
Trade receivables

0

0

Research and development tax credit receivable

0

0

Prepaid expenses, other current assets and other assets

0

0

Operating leases, right-of-use assets

0

0

Accounts payable, accrued expenses and other current liabilities

0

0

Other long-term liabilities

-

0

Operating lease liabilities

0

0

Net cash used in operating activities

0

0

Cash flows from investing activities:
Proceeds from sales and maturities of marketable securities

0

-

Payment of construction deposit

0

-

Purchases of property and equipment

0

0

Net cash provided by (used in) investing activities

0

0

Cash flows from financing activities:
Proceeds from exercise of share options

0

0

Net cash provided by financing activities

0

0

Effect of exchange rate changes on cash, cash equivalents, and restricted cash

0

0

Net increase (decrease) in cash, cash equivalents and restricted cash

0

0

Supplemental disclosure of non-cash investing and financing activities
Property and equipment included in accounts payable and accrued expenses

0

-

Lease assets obtained in exchange for new operating lease liabilities

0

-

Supplemental disclosure of cash flow information:
Cash paid for interest

0

-